Michael Polark
Stock Analyst at Wolfe Research
(3.78)
# 1,929
Out of 4,429 analysts
177
Total ratings
49.4%
Success rate
6%
Average return
Main Sectors:
Stocks Rated by Michael Polark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Initiated Coverage: Hold | $135 | $127.06 | +6.25% | 1 | Jun 1, 2026 | |
| BRKR Bruker | Downgraded: Hold | n/a | $57.23 | - | 1 | Jun 1, 2026 | |
| DHR Danaher | Downgraded: Hold | n/a | $177.17 | - | 1 | Jun 1, 2026 | |
| MTD Mettler-Toledo International | Initiated Coverage: Hold | $1,180 | $1,144.84 | +3.07% | 1 | Jun 1, 2026 | |
| RVTY Revvity | Initiated Coverage: Hold | n/a | $100.00 | - | 1 | Jun 1, 2026 | |
| RGEN Repligen | Initiated Coverage: Buy | $145 | $132.02 | +9.83% | 1 | Jun 1, 2026 | |
| TMO Thermo Fisher Scientific | Initiated Coverage: Buy | $535 | $464.61 | +15.15% | 1 | Jun 1, 2026 | |
| WAT Waters | Maintained: Buy | $425 | $355.44 | +19.57% | 1 | Jun 1, 2026 | |
| WST West Pharmaceutical Services | Rated: Buy | $375 | $327.95 | +14.35% | 1 | Jun 1, 2026 | |
| AVTR Avantor | Rated: Sell | $7 | $9.58 | -26.93% | 1 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $17.54 | +19.73% | 1 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $18.47 | - | 1 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $45.29 | - | 6 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.60 | - | 5 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $88.41 | - | 5 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $92 | $87.36 | +5.31% | 8 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $42.61 | - | 15 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $47 | $35.94 | +30.77% | 1 | Jan 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $79.34 | - | 6 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $13 | $15.63 | -16.83% | 11 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $245 → $270 | $202.61 | +33.26% | 17 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 → $17 | $15.82 | +7.46% | 15 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $13.88 | n/a | 1 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $60 | $78.50 | n/a | 19 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $350 | $145.76 | n/a | 4 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $29 | $19.93 | n/a | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $180 | $188.63 | n/a | 14 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $405 | $307.80 | n/a | 1 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $87.97 | n/a | 1 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $115 | $104.65 | n/a | 19 | Jun 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $3.11 | n/a | 1 | Oct 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $121 → $140 | $72.47 | n/a | 2 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $127.00 | n/a | 3 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $15.30 | n/a | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $315 | $406.78 | n/a | 9 | Apr 5, 2022 |
Agilent Technologies
Jun 1, 2026
Initiated Coverage: Hold
Price Target: $135
Current: $127.06
Upside: +6.25%
Bruker
Jun 1, 2026
Downgraded: Hold
Price Target: n/a
Current: $57.23
Upside: -
Danaher
Jun 1, 2026
Downgraded: Hold
Price Target: n/a
Current: $177.17
Upside: -
Mettler-Toledo International
Jun 1, 2026
Initiated Coverage: Hold
Price Target: $1,180
Current: $1,144.84
Upside: +3.07%
Revvity
Jun 1, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $100.00
Upside: -
Repligen
Jun 1, 2026
Initiated Coverage: Buy
Price Target: $145
Current: $132.02
Upside: +9.83%
Thermo Fisher Scientific
Jun 1, 2026
Initiated Coverage: Buy
Price Target: $535
Current: $464.61
Upside: +15.15%
Waters
Jun 1, 2026
Maintained: Buy
Price Target: $425
Current: $355.44
Upside: +19.57%
West Pharmaceutical Services
Jun 1, 2026
Rated: Buy
Price Target: $375
Current: $327.95
Upside: +14.35%
Avantor
Jun 1, 2026
Rated: Sell
Price Target: $7
Current: $9.58
Upside: -26.93%
Jun 1, 2026
Initiated Coverage: Buy
Price Target: $21
Current: $17.54
Upside: +19.73%
Jun 1, 2026
Downgraded: Hold
Price Target: n/a
Current: $18.47
Upside: -
May 29, 2026
Downgraded: Hold
Price Target: n/a
Current: $45.29
Upside: -
May 13, 2026
Maintained: Hold
Price Target: n/a
Current: $1.60
Upside: -
Apr 16, 2026
Maintained: Hold
Price Target: n/a
Current: $88.41
Upside: -
Apr 1, 2026
Upgraded: Buy
Price Target: $92
Current: $87.36
Upside: +5.31%
Feb 13, 2026
Downgraded: Hold
Price Target: n/a
Current: $42.61
Upside: -
Jan 12, 2026
Initiated Coverage: Buy
Price Target: $47
Current: $35.94
Upside: +30.77%
Aug 25, 2025
Reiterated: Hold
Price Target: n/a
Current: $79.34
Upside: -
Aug 14, 2025
Maintained: Buy
Price Target: $14 → $13
Current: $15.63
Upside: -16.83%
Aug 8, 2025
Maintained: Buy
Price Target: $245 → $270
Current: $202.61
Upside: +33.26%
Aug 8, 2025
Maintained: Buy
Price Target: $19 → $17
Current: $15.82
Upside: +7.46%
May 29, 2025
Initiated Coverage: Buy
Price Target: $20
Current: $13.88
Upside: n/a
May 19, 2025
Upgraded: Buy
Price Target: $60
Current: $78.50
Upside: n/a
May 12, 2025
Upgraded: Buy
Price Target: $350
Current: $145.76
Upside: n/a
Mar 31, 2025
Initiated Coverage: Buy
Price Target: $29
Current: $19.93
Upside: n/a
Sep 17, 2024
Downgraded: Sell
Price Target: $180
Current: $188.63
Upside: n/a
Sep 9, 2024
Initiated Coverage: Buy
Price Target: $405
Current: $307.80
Upside: n/a
Sep 9, 2024
Initiated Coverage: Hold
Price Target: n/a
Current: $87.97
Upside: n/a
Jun 19, 2024
Upgraded: Buy
Price Target: $115
Current: $104.65
Upside: n/a
Oct 19, 2023
Initiated Coverage: Hold
Price Target: n/a
Current: $3.11
Upside: n/a
Jul 28, 2023
Maintained: Buy
Price Target: $121 → $140
Current: $72.47
Upside: n/a
Apr 25, 2023
Downgraded: Hold
Price Target: n/a
Current: $127.00
Upside: n/a
Jan 26, 2023
Initiated Coverage: Hold
Price Target: n/a
Current: $15.30
Upside: n/a
Apr 5, 2022
Initiated Coverage: Hold
Price Target: $315
Current: $406.78
Upside: n/a